Přístupnostní navigace
E-application
Search Search Close
Project detail
Duration: 01.03.2021 — 28.02.2022
Funding resources
Brno University of Technology - Vnitřní projekty VUT
- whole funder (2021-01-01 - 2022-12-31)
On the project
CRISPR/Cas9 has its challenges. There is no technology delivering delivering CRISPR/Cas9 in a cell-specific manner even though it is desirable to edit genes only in target cells and not elsewhere. This applies especially in cancer. In this project, I will be constructing layered nanoparticle with advanced properties delivering CRISPR/Cas9 cell specifically into HER2+ breast cancer cells and knocking-out CXCR4 gene, which is overexpressed in HER2+ breast cancer causing aggressive phenotype and the formation of metastasis.
Mark
CEITEC VUT-J-21-7506
Default language
Czech
People responsible
Heger Zbyněk, doc. - fellow researcherRessnerová Alžběta, M.Sc., MSc - principal person responsible
Units
Central European Institute of Technology BUT- (2021-01-01 - 2021-12-31)Smart Nanodevices- (2021-01-01 - 2021-12-31)